# ENLIGHTEN: Establishing Novel Antiretroviral (ARV) Imaging for Hair to Elucidate Non-Adherence

> **NCT03218592** · PHASE4 · COMPLETED · sponsor: **University of North Carolina, Chapel Hill** · enrollment: 36 (actual)

## Conditions studied

- HIV/AIDS

## Interventions

- **DRUG:** Maraviroc Pill
- **DRUG:** Dolutegravir Pill
- **DRUG:** Truvada Pill

## Key facts

- **NCT ID:** NCT03218592
- **Lead sponsor:** University of North Carolina, Chapel Hill
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-28
- **Primary completion:** 2018-12-03
- **Final completion:** 2018-12-07
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2019-11-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03218592

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03218592, "ENLIGHTEN: Establishing Novel Antiretroviral (ARV) Imaging for Hair to Elucidate Non-Adherence". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03218592. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*